De Burlo Group Has Cut Its Weyerhaeuser Co (WY) Holding as Market Value Declined; Tg Therapeutics (TGTX) Valuation Rose While Hikari Power LTD Boosted by $1.10 Million Its Holding

February 23, 2018 - By Marguerite Chambers

De Burlo Group Inc decreased its stake in Weyerhaeuser Co (WY) by 62.59% based on its latest 2017Q3 regulatory filing with the SEC. De Burlo Group Inc sold 26,100 shares as the company’s stock declined 1.49% while stock markets rallied. The institutional investor held 15,600 shares of the real estate investment trusts company at the end of 2017Q3, valued at $530,000, down from 41,700 at the end of the previous reported quarter. De Burlo Group Inc who had been investing in Weyerhaeuser Co for a number of months, seems to be less bullish one the $26.64B market cap company. The stock increased 1.06% or $0.37 during the last trading session, reaching $35.23. About 991,631 shares traded. Weyerhaeuser Company (NYSE:WY) has risen 8.94% since February 23, 2017 and is uptrending. It has underperformed by 7.76% the S&P500.

Hikari Power Ltd increased its stake in Tg Therapeutics Inc (TGTX) by 166.67% based on its latest 2017Q3 regulatory filing with the SEC. Hikari Power Ltd bought 100,000 shares as the company’s stock rose 144.09% with the market. The institutional investor held 160,000 shares of the health care company at the end of 2017Q3, valued at $1.90 million, up from 60,000 at the end of the previous reported quarter. Hikari Power Ltd who had been investing in Tg Therapeutics Inc for a number of months, seems to be bullish on the $975.00 million market cap company. The stock decreased 1.43% or $0.2 during the last trading session, reaching $13.8. About 458,532 shares traded. TG Therapeutics, Inc. (NASDAQ:TGTX) has risen 60.54% since February 23, 2017 and is uptrending. It has outperformed by 43.84% the S&P500.




Since December 29, 2017, it had 0 insider purchases, and 1 sale for $272,051 activity.

Among 8 analysts covering TG Therapeutics (NASDAQ:TGTX), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. TG Therapeutics had 19 analyst reports since August 12, 2015 according to SRatingsIntel. On Friday, December 1 the stock rating was maintained by B. Riley & Co with “Buy”. The firm has “Strong Buy” rating by Raymond James given on Wednesday, September 9. On Friday, February 2 the stock rating was maintained by FBR Capital with “Buy”. As per Friday, May 27, the company rating was initiated by SunTrust. The firm earned “Buy” rating on Monday, June 5 by Jefferies. H.C. Wainwright maintained TG Therapeutics, Inc. (NASDAQ:TGTX) on Tuesday, March 7 with “Buy” rating. H.C. Wainwright reinitiated TG Therapeutics, Inc. (NASDAQ:TGTX) rating on Wednesday, August 12. H.C. Wainwright has “Buy” rating and $22.0 target. The stock of TG Therapeutics, Inc. (NASDAQ:TGTX) has “Outperform” rating given on Tuesday, December 1 by FBR Capital. Suntrust Robinson initiated it with “Buy” rating and $18 target in Friday, May 27 report. The firm earned “Buy” rating on Wednesday, January 17 by FBR Capital.

Investors sentiment decreased to 1.21 in 2017 Q3. Its down 1.07, from 2.28 in 2017Q2. It dived, as 11 investors sold TGTX shares while 22 reduced holdings. 11 funds opened positions while 29 raised stakes. 35.13 million shares or 3.60% more from 33.91 million shares in 2017Q2 were reported. Public Employees Retirement Association Of Colorado reported 0% in TG Therapeutics, Inc. (NASDAQ:TGTX). Ny State Common Retirement Fund reported 102,853 shares or 0% of all its holdings. Fmr Lc has 6.45M shares for 0.01% of their portfolio. Barclays Public Ltd Co reported 25,921 shares. Great West Life Assurance Can reported 0% stake. Moreover, Artal Sa has 0.08% invested in TG Therapeutics, Inc. (NASDAQ:TGTX) for 400,000 shares. Columbus Circle Invsts has 0.31% invested in TG Therapeutics, Inc. (NASDAQ:TGTX) for 1.53M shares. Legal & General Gru Pcl holds 0% of its portfolio in TG Therapeutics, Inc. (NASDAQ:TGTX) for 12,500 shares. Eam Invsts Ltd Com has 0.49% invested in TG Therapeutics, Inc. (NASDAQ:TGTX) for 308,120 shares. Credit Suisse Ag reported 224,066 shares. California State Teachers Retirement has 0% invested in TG Therapeutics, Inc. (NASDAQ:TGTX). Jennison Assoc reported 1.24M shares. 21,000 are owned by North Star Inv Mngmt. Voya Investment Mgmt Llc reported 0% stake. The Nebraska-based Ameritas Invest Ptnrs has invested 0% in TG Therapeutics, Inc. (NASDAQ:TGTX).

Investors sentiment increased to 1.1 in Q3 2017. Its up 0.09, from 1.01 in 2017Q2. It increased, as 31 investors sold WY shares while 275 reduced holdings. 76 funds opened positions while 261 raised stakes. 551.50 million shares or 0.58% less from 554.73 million shares in 2017Q2 were reported. Mutual Of America Capital Mgmt Limited Liability Corp accumulated 114,240 shares or 0.06% of the stock. Wealthfront stated it has 16,317 shares. Caisse De Depot Et Placement Du Quebec invested in 0.01% or 98,678 shares. Pnc Serv reported 0.01% in Weyerhaeuser Company (NYSE:WY). Van Cleef Asset Managementinc, Ohio-based fund reported 218,820 shares. Hanson And Doremus Invest Mngmt invested in 59,367 shares or 0.71% of the stock. Stephens Ar accumulated 257,119 shares or 0.32% of the stock. National Bank Of America De owns 0.04% invested in Weyerhaeuser Company (NYSE:WY) for 8.24M shares. Van Eck Assocs reported 18,475 shares. Bp Public Ltd Com accumulated 86,000 shares. Moreover, Security Natl Trust has 0.02% invested in Weyerhaeuser Company (NYSE:WY). Assetmark holds 3,803 shares. Wms Ptnrs Lc reported 1.27% stake. Sii Invs Wi holds 0.2% of its portfolio in Weyerhaeuser Company (NYSE:WY) for 104,506 shares. Gofen Glossberg Limited Co Il has invested 0.08% in Weyerhaeuser Company (NYSE:WY).

Among 14 analysts covering Weyerhaeuser Company (NYSE:WY), 8 have Buy rating, 1 Sell and 5 Hold. Therefore 57% are positive. Weyerhaeuser Company had 35 analyst reports since September 11, 2015 according to SRatingsIntel. The rating was downgraded by Dundee Securities to “Neutral” on Friday, August 12. On Friday, November 13 the stock rating was upgraded by Credit Agricole to “Outperform”. The stock of Weyerhaeuser Company (NYSE:WY) earned “Buy” rating by RBC Capital Markets on Wednesday, April 19. As per Friday, December 18, the company rating was downgraded by Dundee Securities. The rating was maintained by Argus Research with “Buy” on Thursday, November 2. The stock of Weyerhaeuser Company (NYSE:WY) has “Buy” rating given on Wednesday, January 24 by Bank of America. RBC Capital Markets maintained Weyerhaeuser Company (NYSE:WY) on Friday, July 28 with “Buy” rating. The firm has “Buy” rating given on Tuesday, September 15 by Bank of America. The stock has “Neutral” rating by UBS on Friday, October 9. RBC Capital Markets maintained Weyerhaeuser Company (NYSE:WY) rating on Monday, September 4. RBC Capital Markets has “Buy” rating and $40.0 target.

Since October 16, 2017, it had 0 buys, and 1 insider sale for $7.97 million activity.

Analysts await Weyerhaeuser Company (NYSE:WY) to report earnings on April, 27. They expect $0.33 EPS, up 50.00% or $0.11 from last year’s $0.22 per share. WY’s profit will be $249.51M for 26.69 P/E if the $0.33 EPS becomes a reality. After $0.31 actual EPS reported by Weyerhaeuser Company for the previous quarter, Wall Street now forecasts 6.45% EPS growth.

De Burlo Group Inc, which manages about $619.44M and $451.20 million US Long portfolio, upped its stake in Visa Inc (NYSE:V) by 12,500 shares to 168,700 shares, valued at $17.75M in 2017Q3, according to the filing. It also increased its holding in Mks Instrument Inc (NASDAQ:MKSI) by 15,800 shares in the quarter, for a total of 113,650 shares, and has risen its stake in Brooks Automation Inc (NASDAQ:BRKS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.